USPTO serial 86803969
CLINICAL CHEMISTRY . . . IT'S WHAT WE DO!
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HOLTZ, ALLISON
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CLINICAL CHEMISTRY . . . IT'S WHAT WE DO!?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon
PATRICK J CONCANNON NUTTER MCCLENNEN & FISH LLP155 SEAPORT BOULEVARD SEAPORT WESTBOSTON, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | diagnostic substances, preparations, and materials, namely, chemical, biological and diagnostic reagents and prepared laboratory media for medical purposes; assay kits and reagents for chemical or immunochemical analysis of body fluids or cell-culture supernatants for medical purposes; diagnostic reagents for medical use, diagnostic calibrators for medical use that are used to calibrate the performance of a medical diagnostic reagent, and diagnostic controls for monitoring the performance of diagnostic reagents and calibrators on an assay device for medical use; kits comprised of diagnostic reagents for medical use; kits comprised of diagnostic calibrators for medical use that are used to calibrate the performance of a medical diagnostic reagent; kits comprised of diagnostic controls diagnostic controls for monitoring the performance of diagnostic reagents and calibrators on an assay device for medical use; and kits comprised of assay kits and reagents for chemical or immunochemical analysis of body fluids or cell-culture supernatants for medical purposes; blood plasmas in the nature of control plasmas; fibrinolytic system reagents for medical purposes; antibodies to fibrinolytic proteins for medical purposes; antibodies to coagulation proteins for medical purposes; chromogenic substrates for medical purposes; biochemical reagents for medical purposes; coagulation inhibitors for use in medical diagnostic testing | ACTIVE | — |
| 010 | diagnostic testing apparatus and instruments, namely, clinical chemistry analyzers, molecular analyzers, hematological analyzers, and immunoassay analyzers for the analysis of biological samples for clinical medical screening, monitoring and diagnostic purposes; kits comprised of clinical chemistry analyzers for medical purposes; kits comprised of molecular analyzers for medical purposes; kits comprised of hematological analyzers for medical purposes; kits comprised of immunoassay analyzers for medical purposes; cuvettes for containing test sample, reagent and calibrator materials all of the aforesaid for the analysis of biological samples for clinical medical screening, monitoring and diagnostic purposes; clinical chemistry analyzers for medical purposes; urine analyzing apparatus for medical use; automatic urine analyzing apparatus and instruments for medical use; bilirubin tester for diagnosis for medical purposes; immunoassay apparatus for diagnosis, namely, turbidimetric agglutination analyzers, radioimmunoassay analyzers, enzyme immunoassay analyzers, fluorescence immunoassay analyzers, and chemiluminescent and bioluminescent immunoassay analyzers for medical purposes; testing and diagnostic apparatus and instruments, namely, urine analyzers, endotoxin analyzers, all for in vitro use for medical purposes; apparatus for measuring the concentration of constituents of the blood, namely, blood analyzers for medical purposes, and parts and fittings for all the aforesaid goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sekisui Diagnostics, LLC
- Other trademarks owned by Sekisui Diagnostics, LLC
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named CLINICAL CHEMISTRY . . . IT'S WHAT WE DO!
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 8, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 8, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 6, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 11, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 11, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 22, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 3, 2017 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 1, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 16, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 15, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 15, 2017 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 15, 2017 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 15, 2017 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 16, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 16, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 16, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 26, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 26, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 26, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2015 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Nov 23, 2015 | ALIE | ASSIGNED TO LIE | — |
| Nov 4, 2015 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Nov 3, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 3, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 2, 2015 | NWAP | NEW APPLICATION ENTERED | — |